CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the Rodman & Renshaw Global Investment Conference on Thursday, September 10, 2009, at 2:00 p.m. ET at the New York Palace Hotel.
